Media-OutReach Newswire The United Laboratories and Novo Nordisk announce exclusive license agreement for UBT251, a GLP-1/GIP/glucagon triple receptor agonist
Society Việt Nam strengthens cooperation in measles prevention with int'l partners as vaccination drops
Media-OutReach Newswire Health2Sync Completes an Oversubscribed Round of US$20 Million to Fuel Market Expansion and Prepares for Public Listing